Skip to content

Rachel Summerfield

University of Michigan–Ann Arbor

2 papers in the library · 1 citation · publishing 2024-2025

Papers

Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats

bioRxiv (Cold Spring Harbor Laboratory) October 14, 2025 Nicholas Kolbman, Amanda Nelson, Rachel Summerfield et al. 1 citation preprint

Psilocybin and DMT, two serotonergic psychedelics, delay the onset of slow-wave sleep and REM sleep, and cause a short-lasting increase in wakefulness and decrease in slow-wave sleep in rats. Psilocybin also reduces REM sleep, decreases theta power and coherence, and increases high gamma power and coherence during wake and slow-wave sleep, as well as increasing high gamma coherence during REM sleep. DMT increases gamma coherence only during wakefulness. The enhanced high gamma functional connectivity suggests that psychedelic-induced changes in neural dynamics can occur independently of arousal states.

Effect of Intravenous Delivery of N,N Dimethyltryptamine on Sleep-Wake States in Rat

Physiology May 1, 2024 Rachel Summerfield, Trent Groenhout, Tiecheng Liu et al.

Intravenous DMT, a psychedelic, increases wakefulness and reduces slow-wave sleep in rats during the first three hours after administration, with a delay in the onset of rapid eye movement sleep. Low (3.75 mg/kg) and high (7.5 mg/kg) doses both produced these effects, while time spent in REM sleep during the light period was unaffected. The findings align with previous reports on serotonergic psychedelics and wakefulness.